Extract from the above information

It can reduce the increase of serum AST and ALT in the animal acute liver injury model caused by TAA (thioacetamide) and CC14 (carbon tetrachloride), and inhibit the accumulation of triglycerides caused by chronic liver injury model; it can promote liver glycogen synthesis, inhibit the increase of cholesterol, and help to restore the serum albumin/globulin ratio.

Used to treat osteoporosis in postmenopausal women. Prevent hip and spinal fractures (vertebral compression fractures). Used to treat male osteoporosis to prevent fractures. This product is a bone metabolism regulator, an aminobisphosphonate, with a strong affinity for hydroxyapatite in the bone. It can enter the hydroxyapatite crystals in the bone matrix. When osteoclasts dissolve the crystals, the drug is released, which can inhibit osteoclast activity and indirectly inhibit bone resorption through osteoblasts. It is characterized by strong anti-bone resorption activity and no bone mineralization inhibition.

Prostaglandin synthesis inhibitor, with anti-inflammatory and analgesic effects. When applied topically, its active ingredients can penetrate the skin to reach the inflamed area, relieve acute and chronic inflammatory reactions, reduce inflammatory swelling and pain, and relieve pain.